Javascript Required
Your browser must have Javascript enabled in order for our dynamic player to be embedded. Please turn on Javascript in your browser preferences and then refresh this page.
Your browser must have Javascript enabled in order for our dynamic player to be embedded. Please turn on Javascript in your browser preferences and then refresh this page.
Related Networks
Related Channels
Related Organizations
Physician Insight:
Trigger Site Ablation
Jonathan S. Steinberg, MD
Heart Disease: The American Heart Association estimates that about two million Americans suffer from the most common form of heart arrhythmia, atrial fibrillation (AFib), which also is responsible for an estimated 70,000 strokes in the United States each year. Most AFib patients are treated with blood thinners, which unfortunately put patients at risk of serious bleeding if they fall or bruise themselves. Those treated through surgery face the typical surgical risks of complications and even death. Chronic medical therapy, the mainstay of AFib treatment, is often ineffective or hazardous. AFib sufferers who are wary of medications or surgery can view a revolutionary, non-surgical, intravenous catheter technique known as radiofrequency ablation therapy, now being performed to treat AFib, via a live Webcast from St. Luke's-Roosevelt Hospital in New York City, on March 3, from 2pm to 3pm.
Participants
Featuring:
Jonathan Steinberg, MD
Chief, Division of Cardiology
Avi Fischer, MD
Attending, Arrhythmia Service
